Patents by Inventor Stephen N. Jones

Stephen N. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosing and treating hematopoietic cancers
    Patent number: 7723055
    Abstract: Described herein are methods and compositions comprising Wnt5a for the diagnosis and treatment of hematopoietic cancers, and methods of identifying therapeutic compounds for the treatment of hematopoietic cancers.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: May 25, 2010
    Assignee: University of Massachusetts
    Inventors: Stephen N. Jones, Huiling Liang, German Pihan
  • Mdm2 splice variants
    Patent number: 7273927
    Abstract: The invention provides polypeptide and polynucleotide splice variants of the mouse Mdm2 gene, including Mdm2-b, which is homologous to the human Hdm2-b variant, as well as host cells, vectors and transgenic mice comprising the variants, and methods for the use thereof.
    Type: Grant
    Filed: November 3, 2004
    Date of Patent: September 25, 2007
    Assignee: University of Massachusetts
    Inventors: Stephen N. Jones, Heather Steinman
  • Regulation of mdm2 function
    Publication number: 20040216178
    Abstract: The invention provides non-human transgenic animals having conditional mdm2 transgenes integrated into their genome, cells derived therefrom, and methods for making and using both.
    Type: Application
    Filed: March 3, 2004
    Publication date: October 28, 2004
    Inventors: Stephen N. Jones, Heather Steinman
  • Transcriptional control element adapted for regulation of gene expression in animal cells
    Patent number: 4775630
    Abstract: A novel alteration of a viral DNA sequence, derived from a human adenovirus type 3 mutant (Ad3) designaed Ad3h15, provides a transcriptional control element which can be used to regulate expression of a selected gene in animal and human cells. The Ad3h15 control element blocks transcription of a controlled gene in the presence of the products of the Ad3 E1A gene, and amplifies transcription in the presence of type 5 (Ad5) adenovirus E1A gene products.
    Type: Grant
    Filed: August 15, 1986
    Date of Patent: October 4, 1988
    Assignee: Vanderbilt University
    Inventors: Clark Tibbetts, Pamela L. Larsen, Stephen N. Jones, Mary M. McGrane